Peculiarities of drug therapy in pediatrics: help of a nurse in organizing medical care for children

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The use of drugs in pediatrics has a number of features and is associated with a number of applied problems. Medical workers are often faced with the prescription of drugs «off-label», lack of drugs in appropriate doses for children and, accordingly, with the need to develop appropriate dosage forms. The article discusses the issues of the safety of the use of drugs in children and the principles of drug provision in pediatrics. The issues of drug provision in pediatrics are considered. It was shown that the largest number of children’s dosage forms was registered in the group of drugs acting on the central nervous system, mainly in the subgroup of analgesics. In the groups of drugs that act on the cardiovascular system, regulate metabolic processes, for the treatment of infectious diseases, children’s dosage forms are presented in an extremely limited number, and in the groups of drugs for the treatment of malignant neoplasms and diagnostic drugs, there are simply no special pediatric dosage forms. The topic is a continuation of an article published in the journal «Medizinskaya Sestra» /Nurse (Rus) in 2020 (Grigoriev K.I. and Vykhristyuk O.F, «Medicines and children. Problems of the XXI century»: vol. 22, №1: 5-14).

Full Text

Restricted Access

About the authors

Konstantin I. Grigoryev

Pirogov’s Russian State National research Medical University, of the Ministry of Health of Russia

Email: k-i-grigoryev@yandex.ru
ORCID iD: 0000-0002-4546-1092
Scopus Author ID: 56848239000

Doctor of Medical Sciences, Professor of the Department of Pediatrics with infectious diseases in children of the faculty of Additional Professional Education, Editor-in-Chief of the Journal «Medical Sister»

Russian Federation,

Lyubov A. Kharitonova

Pirogov’s Russian state national research university of the Ministry of health of the Russian Federation

Email: k-i-grigoryev@yandex.ru
ORCID iD: 0000-0003-2298-7427
Scopus Author ID: 7004072783

Doctor of Medical Sciences, Professor, Head of the Department of Pediatrics with Infectious Diseases in Children of the Faculty of Additional Professional Education

Russian Federation,

Olga F. Vykhristyuk

Pirogov’s Russian state national research university of the Ministry of health of the Russian Federation; RUDN Medical Institute

Email: k-i-grigoryev@yandex.ru
ORCID iD: 0000-0002-0352-9642
Scopus Author ID: 57200041816

Doctor of Medical Sciences, Professor of the Department of Pediatrics, of the Faculty of Medicine, Professor of the Department of Evidence-Based Medicine

Russian Federation,

Lyudmila F. Nemtyreva

I. M. Sechenov’s First Moscow state medical University of the Ministry of health of the Russian Federation (Sechenov University)

Email: k-i-grigoryev@yandex.ru
ORCID iD: 0000-0003-3941-713X
Scopus Author ID: 57215603542

Honored healthcare worker of the Russian Federation, assistant of the Department of nursing and social work management

Russian Federation,

Zulfiya A Rakhmatullina

RUDN Medical Institute

Author for correspondence.
Email: k-i-grigoryev@yandex.ru
ORCID iD: 0000-0003-3403-843X

Assistant of the Department of Evidence-Based Medicine

Russian Federation,

References

  1. Knyazkova I.I. Features of pharmacodynamics of drugs in children: the importance of pharmacogenomics and pharmacogenetics. Pediatrics. 2016; 37. № 2: 42-44.
  2. Namazova-Baranova L.S., Zelenkova I.V., Gubanova S.G., Pashkov A.V., Naumova I.V., Efendieva K.E., Gankovsky V.A. Irrational pharmacotherapy as one of the causes of medical errors. Pediatricheskaya farmakologiya (Pediatric pharmacology). 2021; 18(1):31–37. doi: 10.15690/pf. v18i1.2234
  3. Kotelnikov G.P., Shpigel A.S. The system of introduction and implementation of the principles of evidence-based medicine is a necessary and obligatory component of improving the quality of education in the context of healthcare modernization. Meditsinskoye obrazovaniye i professional’noye razvitiye (Medical education and professional development). 2012; №1(7): 43-46.
  4. Burbello A.T., Fedorenko A.S., Sychev D.A., et al. The value of a professional standard in the work of a clinical pharmacologist in a medical organization. Bulletin of the North-Western State Medical University. I.I. Mechnikov. 2018; vol. 10. № 3: 5–18. doi: 10.17816/mechnikov20181035-18
  5. Shestakov V.N., Polyakov S.V., Persanova L.V., Andreevicheva T.Yu., Veretennikova M.A., Ulyanov A.M., Skupchenko V.V., Lobov A.V. Mamedova D.A., Miranyan K.A., Jafarova T.A. Medicines in pediatrics: problems and perspectives. Ratsional’naya farmakoterapiya. Terapevt (Rational pharmacotherapy. Therapist). 2019; № 11: 57-61.
  6. Solopova A., Vlasina A., Nlkulenkova Yu. Current approaches to rehabilitating children with gynecological cancer Vrach 2019. (30) № 9. С. 3-10
  7. Baranov A., Namazova L., Saitkulov K., Smitienko I. Russian national pediatric formulary and rational use of medicines: modern approaches to patient education. Pediatricheskaya farmakologiya (Pediatric pharmacology). 2006; 3(6): 6-9.
  8. Titova A.R., Asetskaya I.L., Polivanov V.A., Zyryanov S.K. Russian study of off-label drug prescriptions in pediatric practice: 2015 vs 2012. Kachestvennaya klinicheskaya praktika (Quality clinical practice). 2016; № 4: 54–62.
  9. Zyryanov S.K., Sokolov A.V., Belousov Yu.B. Pharmacokinetics of drugs in children of different age groups. Meditsinskiye tekhnologii. Otsenka i vybor (Medical technologies. Evaluation and choice). 2011; № 2: 70–76.
  10. Clavenna A., Bonati M. Adverse drug reactions in childhood: a review of prospective studies and safety alerts. Arch DisChild. 2009; V.94: 724–728.
  11. Narkevich I.A., Nemyatykh O.D., Basakina I.I. Pharmaceutical development of drugs for pediatric practice: fundamentals and specific features. Razrabotka i registratsiya lekarstvennykh sredstv (Development and registration of medicines). 2016; № 3: 194–201.
  12. Belyatskaya A. V., Krasnyuk I. I., Krasnyuk I. I. (Jr.), Stepanova O. I., Korol L. A., Rostopchina O. V. The use of finished drugs in the extemporaneous manufacture of powders. Razrabotka i registratsiya lekarstvennykh sredstv (Development and registration of medicines). 2017; № 1: 82–85.
  13. Polyaev Yu.A., Postnikov S.S., Mylnikov A.A., Narbutov A.G. Place of propranolol in the treatment of infantile hemangiomas. Detskaya bol’nitsa (Children Hospital). 2012; № 4: 46-49.
  14. Kondyurina E.G., Zelenskaya V.V. Therapy of acute respiratory infections in children from the standpoint of evidence-based medicine. Voprosy sovremennoy pediatrii (Questions of modern pediatrics). 2016; 15(6): 568–575. doi: 10.15690/vsp. v15i6.1653
  15. Gudima G.O., Khaitov R.M., Kudlay D.A., Khaitov M.R. Molecular and immunological aspects of the diagnosis, prevention and treatment of coronavirus infection. Immunology. 2021; 42(3): 198–210. DOI: https://doi.org/10.33029/0206-4952-2021-42-3-198-210
  16. Drogovoz S.M., Butko Ya.A., Ivantsik L.B., Shchekina E.G., Belik G.V., Lukyanchuk V.D. Features of the use of off-label drugs in pediatrics. Zaporozhskiy meditsinskiy zhurnal (Zaporozhye Medical Journal). 2020; v. 22, № 5(122): 714-718.
  17. Tulupov D.A., Fedotov F.A., Karpova E.P., Grabovskaya V.A. Modern aspects of the use of nasal vasoconstrictor and auxiliary drugs in pediatric practice. Meditsinskiy sovet (Medical advice). 2018; № 2: 114–117.
  18. Shilov V.V., Derevianko E.S., Al-Madkhun A.I. Modern ideas about acute Naphazoline poisoning in children / Preventive medicine: a collection of conference proceedings. St. Petersburg: North-Western State Medical Institute. university. I.I. Mechnikova, 2019; ch. 2: 208–215.
  19. Gromova O.A. Vitamin D is a paradigm shift. M.: GEOTAR-Media, 2021. 2nd edition – 736 p.
  20. Avdeeva Zh.I., Soldatov A.A., Bondarev V.P., Merkulov V.A. Preparations of monoclonal antibodies in autoimmune diseases (safety issues). Voprosy gematologii/onkologii i immunopatologii v pediatrii (Issues of hematology/oncology and immunopathology in pediatrics). 2020; 19(4): 96-100.
  21. Filippova A.V., Kolbin A.S., Verbitskaya E.V., Glagolev S.V., Polivanov V.A. Systemic characteristics of the safety profile of drugs of monoclonal antibodies used in rheumatological practice. Kachestvennaya klinicheskaya praktika (Quality clinical practice). 2019; (2): 75-84. doi.org/10.24411/2588-0519-2019-10075
  22. Aslanyants S. K., Adzhienko V. L., Kulik V. V. Analysis of the structure of the nomenclature of children’s drugs registered in the Russian Federation. Bulletin of the Volgograd State Medical University. 2016; № 1 (57); 22–24.
  23. Martsevich S.Yu., Navasardyan A.R., Komkova N.A. The prescription of medicines is not in accordance with the official instructions for medical use (off-label). Possible causes, types and consequences. Legal regulation in the Russian Federation. Ratsional’naya farmakoterapiya v kardiologii (Rational pharmacotherapy in cardiology). 2017; vol. 13. № 5: 667–674. doi: 10.20996/1819-6446-2017-13-5-667-674
  24. Egorova S.N., Kondakov S.E., Gordeev V.V., Beletskii S.O., Khayatov A.R., Ikhalainen E.S. Modern problems of drug dosing for children in the Russian Federation. Bulletin of the Smolensk State Medical Academy 2019; vol. 18, № 4: 220-224.
  25. Ivanovska V., Rademaker C.M., van Dijk L., Mantel-Teeuwisse A.K. Pediatric drug formulation: a review of challenges and progress. Pediatrics. 2014; 134(2): 361-372. doi: 10.1542/peds.2013-3225.
  26. Batchelor H. K., Marriott J. F. Formulations for children: problems and solutions. British journal of clinical pharmacology. 2015; T. 79. № 3: 405–418.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1.

Download (25KB)
Indexing metadata

Copyright (c) 2022 Russkiy Vrach Publishing House